Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1258 Views
-
Last post by frodo
-
- 0 Replies
- 927 Views
-
Last post by frodo
-
- 0 Replies
- 2250 Views
-
Last post by NHE
-
- 0 Replies
- 1235 Views
-
Last post by frodo
-
- 0 Replies
- 1190 Views
-
Last post by frodo
-
- 0 Replies
- 1148 Views
-
Last post by frodo
-
- 0 Replies
- 1385 Views
-
Last post by NHE
-
- 0 Replies
- 438 Views
-
Last post by NHE
-
- 1 Replies
- 2862 Views
-
Last post by Tif